美股市场个股详情

IMRN Immuron

添加自选

2.070
+0.118+6.06%

交易中 11/04 15:20 (美东)

1179.89万总市值-2593市盈率TTM

Immuron股票讨论区

登录发表评论

Stock_Drift

10/10 17:14

盘后交易。下午6:12 10/10

$力奇服务 (CLIK.US)$ $天睿祥 (TIRX.US)$ $Immuron (IMRN.US)$ $Indaptus Therapeutics (INDP.US)$ $Currenc Group (CURR.US)$ $LuxUrban Hotels (LUXH.US)$ $Aehr Test Systems (AEHR.US)$ $AGBA Group (AGBA.US)$ $Cemtrex (CETX.US)$ $Blue Star Foods (BSFC.US)$ $NewGenIvf (NIVF.US)$

已翻译

Trytosaveabit

10/04 06:49

更新！停牌从今天开始，而不是周一

$Immuron (IMRN.US)$ 交易暂停：停牌状态于东部时间上午7:45:00更新：行情恢复：资讯和恢复时间将于上午7:50开始交易

已翻译

Trytosaveabit

10/04 05:34

A bit from new 6K

$Immuron (IMRN.US)$ NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

Melbourne, Australia, October 4, 2024: Immuron Limited (ASX: IMC; NASDAQ: IMRN), is an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases. Following discussion with the US Naval Medical Research Command (NMRC), today the Company can announce that ...